Objectives Knowledge is limited on how changing SARS-CoV-2 variants may translate into
different characteristics and affect the prognosis of patients with long COVID, especially …

Long COVID should be limited to patients with multiple, persistent symptoms not related to
well-defined organ damage. Once redefined, a focused review of long COVID demonstrates …

The mechanisms underlying the many phenotypic manifestations of post-acute COVID-19
syndrome (PACS) are poorly understood. Herein, we characterized the gut microbiome in …

Infectious diseases are a cause of major concern in this twenty-first century. There have
been reports of various outbreaks like severe acute respiratory syndrome (SARS) in 2003 …

Background Around 10% of people infected by SARS-COV-2 report symptoms that persist
longer than 3 months. Little has been reported about sex differences in symptoms and …

Introduction A substantial proportion of the over 700 million COVID-19 cases world-wide
experience long-term symptoms. The objectives of this study were to compare symptom …

The rapid development of safe and effective vaccines helped to prevent severe disease
courses after SARS-CoV-2 infection and to mitigate the progression of the COVID-19 …

Objective Persisting neurological symptoms after COVID‐19 affect up to 10% of patients and
can manifest in fatigue and cognitive complaints. Based on recent evidence, we evaluated …

Abstract Background and Objective Long COVID (LC) refers to persistent symptoms after
acute COVID-19 infection, which may endure for months or years. LC affects millions of …

Background The neurological symptoms of Long COVID (LC) and the impact of
neuropsychological manifestations on people's daily lives have been extensively described …